The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Economic Costs of Diabetes in the U.S. in 2007
Open accessAbstract
OBJECTIVE—The prevalence of diabetes continues to grow, with the number of people in the U.S. with diagnosed diabetes now reaching 17.5 million. The objectives of this study are to quantify the economic burden of diabetes caused by increased health resource use and lost productivity, and to provide a detailed breakdown of the costs attributed to diabetes. RESEARCH DESIGN AND METHODS—This study uses a prevalence-based approach that combines the demographics of the population in 2007 with diabetes prevalence rates and other epidemiological data, health care costs, and economic data into a Cost of Diabetes Model. Health resource use and associated medical costs are analyzed by age, sex, type of medical condition, and health resource category. Data sources include national surveys and claims databases, as well as a proprietary database that contains annual medical claims for 16.3 million people in 2006. RESULTS—The total estimated cost of diabetes in 2007 is $174 billion, including $116 billion in excess medical expenditures and $58 billion in reduced national productivity. Medical costs attributed to diabetes include $27 billion for care to directly treat diabetes, $58 billion to treat the portion of diabetes-related chronic complications that are attributed to diabetes, and $31 billon in excess general medical costs. The largest components of medical expenditures attributed to diabetes are hospital inpatient care (50% of total cost), diabetes medication and supplies (12%), retail prescriptions to treat complications of diabetes (11%), and physician office visits (9%). People with diagnosed diabetes incur average expenditures of $11,744 per year, of which $6,649 is attributed to diabetes. People with diagnosed diabetes, on average, have medical expenditures that are ∼2.3 times higher than what expenditures would be in the absence of diabetes. For the cost categories analyzed, ∼$1 in $5 health care dollars in the U.S. is spent caring for someone with diagnosed diabetes, while ∼$1 in $10 health care dollars is attributed to diabetes. Indirect costs include increased absenteeism ($2.6 billion) and reduced productivity while at work ($20.0 billion) for the employed population, reduced productivity for those not in the labor force ($0.8 billion), unemployment from disease-related disability ($7.9 billion), and lost productive capacity due to early mortality ($26.9 billion). CONCLUSIONS—The actual national burden of diabetes is likely to exceed the $174 billion estimate because it omits the social cost of intangibles such as pain and suffering, care provided by nonpaid caregivers, excess medical costs associated with undiagnosed diabetes, and diabetes-attributed costs for health care expenditures categories omitted from this study. Omitted from this analysis are expenditure categories such as health care system administrative costs, over-the-counter medications, clinician training programs, and research and infrastructure development. The burden of diabetes is imposed on all sectors of society—higher insurance premiums paid by employees and employers, reduced earnings through productivity loss, and reduced overall quality of life for people with diabetes and their families and friends.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persons with diabetes are three times more likely to be hospitalized than those without diabetes, and approximately 25% of hospitalized patients (including people without a history of diabetes) have hyperglycemia (62–65).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [62]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Persons with diabetes are three times more likely to be hospitalized than those without diabetes, and approximately 25% of hospitalized patients (including people without a history of diabetes) have hyperglycemia (62–65).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [62]
Experimental — accuracy not yet measuredIn the citing paper
“Persons with diabetes are three times more likely to be hospitalized than those without diabetes, and approximately 25% of hospitalized patients (including people without a history of diabetes) have hyperglycemia (62 -65).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [62]
In the citing paper
“Persons with diabetes are three times more likely to be hospitalized than those without diabetes, and approximately 25% of hospitalized patients (including people without a history of diabetes) have hyperglycemia (62 -65).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [62]
In the citing paper
“Yet at least 25% of subjects with T2DM are undiagnosed, 18 and they are often concentrated within a hypertriglyceridemic population.”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Self-citationGoetzel, R. Z., Long, S. R., Ozminkowski, R. J., Hawkins, K., Wang, S., & Lynch, W. (2004) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000121151.40413.bd · Cited by 1,259
Okura, Y., Urban, L. H., Mahoney, D. W., Jacobsen, S. J., & Rodeheffer, R. J. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.04.005 · Cited by 1,254
Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population
Cowie, C. C., Rust, K. F., Byrd-Holt, D. D., Eberhardt, M. S., Flegal, K. M., Engelgau, M. M., Saydah, S. H., Williams, D. E., Geiss, L. S., & Gregg, E. W. (2006) · Diabetes Care · doi:10.2337/dc06-0062 · Cited by 1,210
The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S.
Gordois, A., Scuffham, P., Shearer, A. T., Oglesby, A. K., & Tobian, J. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1790 · Cited by 735
Goetzel, R. Z., Hawkins, K., Ozminkowski, R. J., & Wang, S. S. (2003) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200301000-00007 · Cited by 694
Economic Consequences of Diabetes Mellitus in the U.S. in 1997
American Diabetes Association (1998) · Diabetes Care · doi:10.2337/diacare.21.2.296 · Cited by 654
Self-citationImpact of Recent Increase in Incidence on Future Diabetes Burden
Narayan, K. M. V., Boyle, J. P., Geiss, L. S., Saaddine, J. B., & Thompson, T. J. (2006) · Diabetes Care · doi:10.2337/dc06-1136 · Cited by 602
Begley, C. E., Famulari, M., Annegers, J. F., Lairson, D. R., Reynolds, T. F., Coan, S. P., Dubinsky, S., Newmark, M. E., Leibson, C. L., So, E. L., et al. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00166.x · Cited by 599
A review of adjusted estimators of attributable risk
Bénichou, J. (2001) · Statistical Methods in Medical Research · doi:10.1177/096228020101000303 · Cited by 440
Flagged first, then by citations
Research works printed but not linked: 1
- Brown DA, Unrein C: A review of cardiovascular comorbidities of diabetes. Am J Managed Care 13:3–10, 2007
Cited by
Sorted by citations
Items 101–200 of 1,001
Estimating the Cost of Type 1 Diabetes in the U.S.: A Propensity Score Matching Method
Tao, B., Pietropaolo, M., Atkinson, M., Schatz, D., & Taylor, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011501 · Cited by 197
Price, J. H., Khubchandani, J., McKinney, M., & Braun, R. (2013) · BioMed Research International · doi:10.1155/2013/787616 · Cited by 198
Diabetes epidemic sweeping the Arab world
Abuyassin, B., & Laher, I. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i8.165 · Cited by 195
The cost of diabetes care-an elephant in the room
Riddle, M. C., & Herman, W. H. (2018) · Diabetes Care · doi:10.2337/dci18-0012 · Cited by 191
The Double Burden of Malnutrition
Shrimpton, R., & Rokx, C. (2012) · World Bank, Washington, DC eBooks · doi:10.1596/27417 · Cited by 188
Burden of Diabetes on the Ability to Work
Breton, M.-C., Guénette, L., Amiche, M. A., Kayibanda, J. F., Grégoire, J., & Moisan, J. (2013) · Diabetes Care · doi:10.2337/dc12-0354 · Cited by 188
Thakkar, B., Aronis, K. N., Vamvini, M. T., Shields, K. S., & Mantzoros, C. S. (2013) · Metabolism · doi:10.1016/j.metabol.2013.01.014 · Cited by 188
Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation
Nichols, G. A., Reinier, K., & Chugh, S. S. (2009) · Diabetes Care · doi:10.2337/dc09-0939 · Cited by 181
The system of care for the diabetic foot: objectives, outcomes, and opportunities
Barshes, N. R., Sigireddi, M., Wrobel, J. S., Mahankali, A., Robbins, J. M., Kougias, P., & Armstrong, D. G. (2013) · Diabetic Foot & Ankle · doi:10.3402/dfa.v4i0.21847 · Cited by 196
Economic costs of diabetes in Saudi Arabia
Alhowaish, A. (2013) · Journal of Family and Community Medicine · doi:10.4103/2230-8229.108174 · Cited by 183
Weinstock, T. G., Wang, X., Rueschman, M., Ismail-Beigi, F., Aylor, J., Babineau, D. C., Mehra, R., & Redline, S. (2012) · Sleep · doi:10.5665/sleep.1816 · Cited by 181
The economic costs of diabetes: a population-based study in Tehran, Iran
Esteghamati, A., Khalilzadeh, O., Anvari, M., Meysamie, A., Abbasi, M., Forouzanfar, M. H., & Alaeddini, F. (2009) · Diabetologia · doi:10.1007/s00125-009-1398-4 · Cited by 180
Functional Dyspepsia Impacts Absenteeism and Direct and Indirect Costs
Brook, R. A., Kleinman, N. L., Choung, R. S., Melkonian, A. K., Smeeding, J., & Talley, N. J. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.03.003 · Cited by 180
Validating ICD coding algorithms for diabetes mellitus from administrative data
Chen, G., Khan, N. A., Walker, R., & Quan, H. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.03.007 · Cited by 177
Espeland, M. A., Glick, H. A., Bertoni, A., Brancati, F. L., Bray, G. A., Clark, J. M., Curtis, J. M., Egan, C., Evans, M., Foreyt, J. P., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0093 · Cited by 174
Costs and Benefits Associated With Diabetes Education A Review of the Literature
Boren, S. A., Fitzner, K. A., Panhalkar, P. S., & Specker, J. E. (2009) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721708326774 · Cited by 171
Assessing the value of diabetes education
Duncan, I., Birkmeyer, C., Coughlin, S., Li, Q., Sherr, D., & Boren, S. (2009) · The Diabetes Educator · doi:10.1177/0145721709343609 · Cited by 170
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, Å., Metzger, B. E., & Nathan, D. M. (2011) · Diabetes Care · doi:10.2337/dc11-9997 · Cited by 170
Lee, D.-C., Sui, X., Church, T. S., Lee, I.-M., & Blair, S. N. (2009) · Diabetes Care · doi:10.2337/dc08-1377 · Cited by 169
Alcohol and type 2 diabetes. A review
Pietraszek, A., Gregersen, S., & Hermansen, K. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.05.001 · Cited by 175
Boyhan, D., & Daniell, H. (2010) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2010.00582.x · Cited by 165
The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus
Janssen, M. F., Lubetkin, E. I., Sekhobo, J. P., & Pickard, A. S. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03136.x · Cited by 165
Egg Consumption and Risk of Type 2 Diabetes in Men and Women
Djoussé, L., Gaziano, J. M., Buring, J. E., & Lee, I.-M. M. (2008) · Diabetes Care · doi:10.2337/dc08-1271 · Cited by 162
Economic costs associated with acute attacks and long-term management of hereditary angioedema
Wilson, D. A., Bork, K., Shea, E. P., Rentz, A. M., Blaustein, M. B., & Pullman, W. E. (2010) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2010.01.024 · Cited by 160
Clarke, P. M., Glasziou, P., Patel, A., Chalmers, J., Woodward, M., Harrap, S. B., Salomon, J. A., & on behalf of the ADVANCE Collaborative Group (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000236 · Cited by 159
Priorities for Screening and Treatment of Latent Tuberculosis Infection in the United States
Linas, B. P., Wong, A. Y., Freedberg, K. A., & Horsburgh, C. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0181oc · Cited by 160
Ahmad, J. (2015) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2015.04.002 · Cited by 169
Hutter, N., Schnurr, A., & Baumeister, H. (2010) · Diabetologia · doi:10.1007/s00125-010-1873-y · Cited by 155
Nurses’ role in diabetic foot prevention and care; a review
Aalaa, M., Tabatabaei‐Malazy, O., Sanjari, M., Peimani, M., & Mohajeri-Tehrani, M. (2012) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-11-24 · Cited by 153
Ralston, E. P., Kite-Powell, H. L., & Beet, A. (2011) · Journal of Water and Health · doi:10.2166/wh.2011.157 · Cited by 156
The relationship of depression and diabetes: Pathophysiological and treatment implications
Rustad, J. K., Musselman, D. L., & Nemeroff, C. B. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.03.005 · Cited by 194
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 164
The genetics of diabetic complications
Ahlqvist, E., van Zuydam, N. R., Groop, L., & McCarthy, M. I. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.37 · Cited by 153
Aging, Diabetes, and the Public Health System in the United States
Caspersen, C. J., Thomas, G. D., Boseman, L. A., Beckles, G. L., & Albright, A. L. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300616 · Cited by 162
Desai, N. R., Shrank, W. H., Fischer, M. A., Avorn, J., Liberman, J. N., Schneeweiß, S., Pakes, J., Brennan, T. A., & Choudhry, N. K. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.07.033 · Cited by 151
Fu, J., Woods, C. G., Yehuda‐Shnaidman, E., Zhang, Q., Wong, V. A., Collins, S., Sun, G., Andersen, M. E., & Pi, J. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901608 · Cited by 173
Türkmen, K. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1488-4 · Cited by 153
Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention
DeFronzo, R. A., & Abdul‐Ghani, M. A. (2011) · Diabetes Care · doi:10.2337/dc11-s221 · Cited by 150
Effect of Diabetes Mellitus on Pharmacokinetic and Pharmacodynamic Properties of Drugs
Dostálek, M., Akhlaghi, F., & Puzanovova, M. (2012) · Clinical Pharmacokinetics · doi:10.1007/bf03261926 · Cited by 150
The cost of diabetes in adults in Australia
Lee, C., Colagiuri, R., Magliano, D. J., Cameron, A. J., Shaw, J. E., Zimmet, P., & Colagiuri, S. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.12.002 · Cited by 146
Translational nanomedicine: status assessment and opportunities
Murday, J. S., Siegel, R. W., Stein, J. A., & Wright, J. F. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.06.001 · Cited by 153
Keating, C. L., Dixon, J. B., Moodie, M., Peeters, A., Bulfone, L., Magliano, D. J., & O’Brien, P. E. (2009) · Diabetes Care · doi:10.2337/dc08-1749 · Cited by 149
The hypoglycaemic effect of pumpkins as anti-diabetic and functional medicines
Adams, G. G., Imran, S., Wang, S., Mohammad, A., Kok, S., Gray, D. A., Channell, G. A., Morris, G. A., & Harding, S. E. (2011) · Food Research International · doi:10.1016/j.foodres.2011.03.016 · Cited by 175
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, Å., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.163634 · Cited by 142
The socioeconomics of diabetes from a developing country: A population based cost of illness study
Tharkar, S., Devarajan, A., Kumpatla, S., & Viswanathan, V. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.05.009 · Cited by 143
Norman, J. J., Brown, M. R., Raviele, N., Prausnitz, M. R., & Felner, E. I. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12031 · Cited by 142
The compressive mechanical properties of diabetic and non-diabetic plantar soft tissue
Pai, S., & Ledoux, W. R. (2010) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2010.02.021 · Cited by 139
Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype
Asleh, R., Blum, S., Kalet-Litman, S., Alshiek, J. A., Miller‐Lotan, R., Asaf, R., Rock, W., Aviram, M., Milman, U., Shapira, C., et al. (2008) · Diabetes · doi:10.2337/db08-0450 · Cited by 140
Building Risk Prediction Models for Type 2 Diabetes Using Machine Learning Techniques
Xie, Z., Nikolayeva, O., Luo, J., & Li, D. (2019) · Preventing Chronic Disease · doi:10.5888/pcd16.190109 · Cited by 153
Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran
Javanbakht, M., Baradaran, H. R., Mashayekhi, A., Haghdoost, A. A., Khamseh, M. E., Kharazmi, E., & Sadeghi, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026864 · Cited by 135
AMG 837: A potent, orally bioavailable GPR40 agonist
Houze, J. B., Zhu, L., Sun, Y., Akerman, M., Qiu, W., Zhang, A. J., Sharma, R. K., Schmitt, M., Wang, Y., Liu, J., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.118 · Cited by 134
Afroz, A., Alramadan, M. J., Hossain, M. N., Romero, L., Alam, K., Magliano, D. J., & Billah, B. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3772-8 · Cited by 149
Diabetes microvascular complications—A clinical update
Khalil, H. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.12.022 · Cited by 147
Karve, A. M., & Hayward, R. A. (2010) · Diabetes Care · doi:10.2337/dc09-1957 · Cited by 141
Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes
Abdul‐Ghani, M. A., & DeFronzo, R. A. (2009) · Diabetes Care · doi:10.2337/dc09-s309 · Cited by 131
Impact of A1C Screening Criterion on the Diagnosis of Pre-Diabetes Among U.S. Adults
Mann, D. M., Carson, A. P., Shimbo, D., Fonseca, V. A., Fox, C. S., & Muntner, P. (2010) · Diabetes Care · doi:10.2337/dc10-0752 · Cited by 131
Periodontal disease and diabetes mellitus
Negrato, C. A., Tárzia, O., Jovanovič, L., & Chinellato, L. E. M. (2013) · Journal of Applied Oral Science · doi:10.1590/1678-7757201302106 · Cited by 130
National Health Spending By Medical Condition, 1996–2005
Roehrig, C., Miller, G. W., Lake, C., & Bryant, J. (2009) · Health Affairs · doi:10.1377/hlthaff.28.2.w358 · Cited by 129
Cost-of-illness studies of diabetes mellitus: A systematic review
Ng, C. S., Lee, J. Y. C., Toh, M. P. H., & Ko, Y. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.03.020 · Cited by 134
Robertson, M. D., Wright, J. W., Loizon, E., Debard, C., Vidal, H., Shojaee-Moradie, F., Russell-Jones, D., & Umpleby, A. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1513 · Cited by 126
High-dose Insulin Therapy: is it Time for U-500 Insulin?
Lane, W. S., Cochran, E. K., Jackson, J. A., Scism-Bacon, J. L., Corey, I. B., Hirsch, I. B., & Skyler, J. S. (2009) · Endocrine Practice · doi:10.4158/ep.15.1.71 · Cited by 124
Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes
Fu, A. Z., Qiu, Y., & Radican, L. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902905724 · Cited by 124
A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease
Ahmad, O. S., Morris, J. A., Mujammami, M. H., Forgetta, V., Leong, A., Li, R., Turgeon, M., Greenwood, C. M. T., Thanassoulis, G., Meigs, J. B., et al. (2015) · Nature Communications · doi:10.1038/ncomms8060 · Cited by 128
Al‐Maskari, F., Sadig, M. E., & Nagelkerke, N. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-679 · Cited by 123
Diabetes mellitus does not adversely affect outcomes from a critical illness*
Graham, B. B., Keniston, A., Gajic, O., Trillo‐Alvarez, C., Medvedev, S., & Douglas, I. S. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b9eaa5 · Cited by 126
The Association Between Personal Health Record Use and Diabetes Quality Measures
Tenforde, M. W., Nowacki, A. S., Jain, A., & Hickner, J. M. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1889-0 · Cited by 121
Sieverdes, J. C., Sui, X., Lee, D.-C., Church, T. S., McClain, A. C., Hand, G. A., & Blair, S. N. (2009) · British Journal of Sports Medicine · doi:10.1136/bjsm.2009.062117 · Cited by 122
Hirsch, I. B., Bode, B. W., Childs, B. P., Close, K. L., Fisher, W. A., Gavin, J. R., Ginsberg, B. H., Raine, C. H., & Verderese, C. A. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0104 · Cited by 121
Brown, H. S., Wilson, K. J., Pagán, J. A., Arcari, C. M., Martinez, M. L., Smith, K. L., & Reininger, B. M. (2012) · Preventing Chronic Disease · doi:10.5888/pcd9.120074 · Cited by 119
Pollack, M. F., Waterman, F., Bolge, S. C., & Williams, S. A. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.11.023 · Cited by 123
Validity of diabetes self-reports in the Women’s Health Initiative
Jackson, J., DeFor, T. A., Crain, A. L., Kerby, T. J., Strayer, L., Lewis, C. E., Whitlock, E. P., Williams, S. B., Vitolins, M. Z., Rodabough, R. J., et al. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000189 · Cited by 122
Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers
Hicks, C. W., Selvarajah, S., Mathioudakis, N. N., Perler, B. A., Freischlag, J. A., Black, J. H., & Abularrage, C. J. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.05.009 · Cited by 118
Javanbakht, M., Mashayekhi, A., Baradaran, H. R., Haghdoost, A. A., & Afshin, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132505 · Cited by 117
Mata‐Cases, M., Casajuana‐Closas, M., Franch‐Nadal, J., Casellas, A., Castell, C., Vinagre, I., Mauricio, D., & Bolíbar, B. (2015) · The European Journal of Health Economics · doi:10.1007/s10198-015-0742-5 · Cited by 116
Redmon, J. B., Bertoni, A. G., Connelly, S., Feeney, P. A., Glasser, S. P., Glick, H. A., Greenway, F. L., Hesson, L. A., Lawlor, M. S., Montez, M. G., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2090 · Cited by 117
Vreman, R. A., Goodell, A. J., Rodríguez, L. A., Porco, T. C., Lustig, R. H., & Kahn, J. G. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013543 · Cited by 116
A Diet High in Low-Fat Dairy Products Lowers Diabetes Risk in Postmenopausal Women
Margolis, K. L., Wei, F., de Boer, I. H., Howard, B. V., Liu, S., Manson, J. E., Mossavar‐Rahmani, Y., Phillips, L. S., Shikany, J. M., & Tinker, L. F. (2011) · Journal of Nutrition · doi:10.3945/jn.111.143339 · Cited by 112
de Bruin, S. R., Heijink, R., Lemmens, L. C., Struijs, J. N., & Baan, C. A. (2011) · Health Policy · doi:10.1016/j.healthpol.2011.03.006 · Cited by 111
Complications of diabetes in China: health system and economic implications
Mao, W., Yip, C.-M., & Chen, W. (2019) · BMC Public Health · doi:10.1186/s12889-019-6569-8 · Cited by 111
Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases
Saha, S., Gerdtham, U., & Johansson, P. (2010) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph7083150 · Cited by 112
Adverse Drug Reactions in Children: The Double‐Edged Sword of Therapeutics
Elzagallaai, A. A., Greff, M., & Rieder, M. J. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.677 · Cited by 109
Aloe vera as an herbal medicine in the treatment of metabolic syndrome: A review
Shakib, Z., Shahraki, N., Razavi, B. M., & Hosseinzadeh, H. (2019) · Phytotherapy Research · doi:10.1002/ptr.6465 · Cited by 109
Png, M. E., Yoong, J., Phan, T. P., & Wee, H. L. (2016) · BMC Public Health · doi:10.1186/s12889-016-2827-1 · Cited by 106
Stearns, A. T., Balakrishnan, A., Rhoads, D. B., & Tavakkolizadeh, A. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181d96e1f · Cited by 106
Type 2 diabetes mellitus in Bangladesh: a prevalence based cost-of-illness study
Afroz, A., Alam, K., Ali, L., Karim, A., Alramadan, M. J., Habib, S. H., Magliano, D. J., & Billah, B. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4440-3 · Cited by 105
Ammons, M. C. B., Ward, L. S., Fisher, S. T., Wolcott, R. D., & James, G. A. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.08.013 · Cited by 106
Schneider, A. L. C., Kalyani, R. R., Golden, S., Stearns, S. C., Wruck, L., Yeh, H. C., Coresh, J., & Selvin, E. (2016) · Diabetes Care · doi:10.2337/dc15-1335 · Cited by 102
Nurse diabetes case management interventions and blood glucose control: Results of a meta-analysis
Welch, G. W., Garb, J., Zagarins, S., Lendel, I., & Gabbay, R. A. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.12.026 · Cited by 102
Baldwin, D., Zander, J., Munoz, C., Raghu, P., DeLange-Hudec, S., Lee, H., Emanuele, M. A., Glossop, V., Smallwood, K., & Molitch, M. (2012) · Diabetes Care · doi:10.2337/dc12-0578 · Cited by 103
Hsia, E., Seggelke, S., Gibbs, J., Hawkins, R. M., Cohlmia, E., Rasouli, N., Wang, C., Kam, I., & Draznin, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1244 · Cited by 112
Mitochondrial metabolism and diabetes
Kwak, S. H., Park, K. S., Lee, K., & Lee, H. K. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00047.x · Cited by 103
Parker, A. R., Byham-Gray, L., Denmark, R., & Winkle, P. J. (2014) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2014.07.020 · Cited by 92
Huang, Y., Shiyanbola, O. O., & Smith, P. D. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s153312 · Cited by 105
Zhu, W. J., Chen, M., Shou, Q., Li, Y., & Hu, F. (2010) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/neq025 · Cited by 97
Ammons, M. C. B., Ward, L. S., & James, G. A. (2011) · International Wound Journal · doi:10.1111/j.1742-481x.2011.00781.x · Cited by 98
The role of stem cells in the treatment of diabetic foot ulcers
Blumberg, S. N., Berger, A. J., Hwang, L. A., Pastar, I., Warren, S. M., & Chen, W. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.10.032 · Cited by 97
Leong, A., Dasgupta, K., Bernatsky, S., Lacaille, D. V., Aviña-Zubieta, A., & Rahme, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075256 · Cited by 99
Mofrad, S. A., Foadoddini, M., Saadatjoo, S. A., & Shayesteh, M. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0137-2 · Cited by 106
Estimated Lifetime Economic Burden of Type 1 Diabetes
Sussman, M., Benner, J., Haller, M. J., Rewers, M., & Griffiths, R. I. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0398 · Cited by 97
Screening Adults for Pre-Diabetes and Diabetes May Be Cost-Saving
Chatterjee, R., Narayan, K. M. V., Lipscomb, J., & Phillips, L. S. (2010) · Diabetes Care · doi:10.2337/dc10-0054 · Cited by 99
Metadata
- Authors
- American Diabetes Association
- Affiliations
- American Diabetes Association (US)
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2008-03-01
- Volume
- 31
- Issue
- 3
- Pages
- 596-615
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4246288537
- Cited by
- 1,323
- References
- 32
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 11 · 2023: 25 · 2022: 19 · 2021: 26 · 2020: 21 · 2019: 33 · 2018: 38 · 2017: 50 · 2016: 79 · 2015: 75 · 2014: 95 · 2013: 130 · 2012: 157
- FWCI
- 58.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- diabetes mellitus, economic burden of disease, health care costs, productivity loss, absenteeism, unemployment, diabetes complications, inpatient care, economic burden, diabetes prevalence, early mortality, employer-sponsored health insurance, physician visits
- MeSH terms
- Diabetes Mellitus, Humans, United States, Health Care Costs, Cost of Illness, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
